FIELD: medicine.
SUBSTANCE: disclosed in the document are methods for selective treatment of atopic dermatitis (AD) in a subject with skin excoriation, pharmaceutical compositions for application in treatment of atopic dermatitis in a subject with skin excoriation, applications of nemolizumab or an equivalent thereof in production of a medicinal product for treatment of atopic dermatitis in a subject with skin excoriation, and methods for identifying a subject with atopic dermatitis capable of responding to treatment with nemolizumab or an equivalent thereof.
EFFECT: developed application of nemolizumab in treatment of AD.
24 cl, 7 dwg, 12 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF ATOPIC DERMATITIS THROUGH INTRODUCTION OF IL-4R INHIBITOR | 2019 |
|
RU2801204C2 |
| USE OF IL-13 ANTAGONISTS FOR THE TREATMENT OF ATOPIC DERMATITIS | 2017 |
|
RU2752785C2 |
| WAY OF TREATMENT OF ATOPIC DERMATITIS | 2007 |
|
RU2361604C1 |
| METHODS FOR TREATING SEVERE ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR | 2017 |
|
RU2759630C2 |
| METHOD OF TREATING SKIN INFECTION BY ADMINISTERING ANTAGONIST IL-4R | 2015 |
|
RU2704999C2 |
| METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING IL-4R ANTAGONIST | 2013 |
|
RU2666630C2 |
| METHODS OF TREATING ATOPIC DERMATITIS WITH THE HELP OF IL-4R ANTAGONIST | 2013 |
|
RU2698907C2 |
| TREATMENT OF SKIN LESIONS AND ITCHING IN PATIENTS WITH PRURIGO NODOSUM | 2020 |
|
RU2822134C2 |
| METHOD OF TREATING ATOPIC DERMATITIS | 2011 |
|
RU2468835C1 |
| METHODS OF TREATING DISEASES ASSOCIATED WITH S1P1 RECEPTOR | 2021 |
|
RU2821032C1 |
